Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.39

-3.1%

2:04 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (5406)	1/11/2002 8:59:33 PM
From: Miljenko Zuanic	Read Replies (4) of 52153

Last year we have dozens failure of the high ranking cancer candidates. But in last few weeks all records are broken. So far we have PCYC, IMCL, CRXA, NEOL, NPRO, DNDN, IDPH, ... Who is next? Miljenko PS: Welcome to crowded cancer field. PSS: Wasn't last year several predictions (from experts and analysts) that cancer field will generate enormous revenue for new drugs and substantial return to investors, quickly?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next